RESEARCH-USE BIOSIMILAR ANTIBODY
Vofatamab
Monoclonal antibody · IgG1
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC). Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
TARGETFGFR3
YMonoclonal antibody
CATALOGSC-BS-034
CATALOG NUMBERSC-BS-034
MOLECULAR WEIGHTApprox. 146.44 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC). Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
Vofatamab is a recombinant research-use antibody directed against FGFR3.